Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
Descripción del Articulo
Background: To assess the correlation of WHO histological classification and Masaoka-Koga staging system of thymic epithelial tumors (TETs) with prognosis. Methods: We retrospectively analyzed 83 patients with TETs in the Instituto Nacional de Enfermedades Neoplasicas between 1996 to 2018. We analyz...
| Autores: | , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2021 |
| Institución: | Instituto Nacional de Enfermedades Neoplásicas |
| Repositorio: | INEN-Institucional |
| Lenguaje: | inglés |
| OAI Identifier: | oai:repositorio.inen.sld.pe:20.500.14703/102 |
| Enlace del recurso: | https: //doi.org/10.1111/1759-7714.13760 https://hdl.handle.net/20.500.14703/102 |
| Nivel de acceso: | acceso abierto |
| Materia: | Masaoka-Koga stage WHO classification prognostic factors thymic epithelial tumors https://purl.org/pe-repo/ocde/ford#3.02.21 |
| id |
INEN_c1b135091b870814966dcebaad59d147 |
|---|---|
| oai_identifier_str |
oai:repositorio.inen.sld.pe:20.500.14703/102 |
| network_acronym_str |
INEN |
| network_name_str |
INEN-Institucional |
| repository_id_str |
. |
| spelling |
PublicationRioja, PJRuiz RJGalvez-Nino, MJLozano, SJValdiviezo, NJOlivera, MJCabero, OJGuillen, MEJDe La Guerra, AJAmorin, EJBarrionuevo, CJMas, L2024-06-13T15:50:48Z2024-06-13T15:50:48Z2021https: //doi.org/10.1111/1759-7714.13760https://hdl.handle.net/20.500.14703/102Thorac CancerBackground: To assess the correlation of WHO histological classification and Masaoka-Koga staging system of thymic epithelial tumors (TETs) with prognosis. Methods: We retrospectively analyzed 83 patients with TETs in the Instituto Nacional de Enfermedades Neoplasicas between 1996 to 2018. We analyzed the clinical stages, histological types and treatment modalities and attempted to determine the impact on overall survival. The data was retrieved from clinical files and reviewed by a pathologist who reclassificated according to the 2004 WHO classification system. The staging was performed with the Masaoka-Koga staging system. Survival curves were constructed with Kaplan-Meir method. Results: There was a total of 83 patients with a median age of 55 years old included in the study. The histological type corresponded to thymoma (T) in 63.8% (n = 53) and to thymic carcinoma (TC) in 36.1%. T were type A, AB, B1, B2 and B3 in 14.4%, 18%, 12%, 3.6%, 7.4% of cases, respectively. The proportion of advanced disease (Masaoka stage III-IV) was high (65%). With a median follow-up of 88.4 months, median overall survival (OS) was 81.6 months for T and 12.3 months for TC (P = 0.01). Univariate analysis showed that sex, histological type, clinical stage and surgery (P = 0.01) were significant independent prognostic factors. On multivariate analysis, histology type and Masaoka-Koga staging had an effect on survival. Conclusions: The results indicates a clear association between the WHO histological classification and Masaoka-Koga staging system with survival. We found a higher proportion of TETs with advanced disease at diagnosis. Further research are required and collaboration is important to foster knowledge focused on classification and treatment.application/pdfengInternational Association for the Study of Lung CancerUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Masaoka-Koga stageWHO classificationprognostic factorsthymic epithelial tumorshttps://purl.org/pe-repo/ocde/ford#3.02.21Epidemiology of thymic epithelial tumors: 22-years experience from a single-institutioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALP Rioja 2021.pdfapplication/pdf535176https://repositorio.inen.sld.pe/backend/api/core/bitstreams/e13a67f0-b5c0-4c85-b3b3-a61085d76772/downloadcfce7875a2f3128e1f599e2c9b37e1a0MD51trueAnonymousREADTEXTP Rioja 2021.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-03-29T20:41:34Z (GMT).Extracted texttext/plain27569https://repositorio.inen.sld.pe/backend/api/core/bitstreams/cb661171-7f18-4d2b-aa2c-aeb764e6fdd7/download45029c6da8048d7f4c68d3a9fb9586dbMD54falseAnonymousREADTHUMBNAILP Rioja 2021.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-03-29T20:41:34Z (GMT).Generated Thumbnailimage/jpeg36808https://repositorio.inen.sld.pe/backend/api/core/bitstreams/74f0fcaa-d942-476e-9633-f3ceb095bfe9/downloadcaddb68e3efa8a9f06440735f26465f9MD55falseAnonymousREAD20.500.14703/102oai:repositorio.inen.sld.pe:20.500.14703/1022026-02-15T21:37:23.419Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe |
| dc.title.none.fl_str_mv |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| title |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| spellingShingle |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution Rioja, PJ Masaoka-Koga stage WHO classification prognostic factors thymic epithelial tumors https://purl.org/pe-repo/ocde/ford#3.02.21 |
| title_short |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| title_full |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| title_fullStr |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| title_full_unstemmed |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| title_sort |
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution |
| author |
Rioja, PJ |
| author_facet |
Rioja, PJ Ruiz RJ Galvez-Nino, MJ Lozano, SJ Valdiviezo, NJ Olivera, MJ Cabero, OJ Guillen, MEJ De La Guerra, AJ Amorin, EJ Barrionuevo, CJ Mas, L |
| author_role |
author |
| author2 |
Ruiz RJ Galvez-Nino, MJ Lozano, SJ Valdiviezo, NJ Olivera, MJ Cabero, OJ Guillen, MEJ De La Guerra, AJ Amorin, EJ Barrionuevo, CJ Mas, L |
| author2_role |
author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Rioja, PJ Ruiz RJ Galvez-Nino, MJ Lozano, SJ Valdiviezo, NJ Olivera, MJ Cabero, OJ Guillen, MEJ De La Guerra, AJ Amorin, EJ Barrionuevo, CJ Mas, L |
| dc.subject.none.fl_str_mv |
Masaoka-Koga stage WHO classification prognostic factors thymic epithelial tumors |
| topic |
Masaoka-Koga stage WHO classification prognostic factors thymic epithelial tumors https://purl.org/pe-repo/ocde/ford#3.02.21 |
| dc.subject.ocde.none.fl_str_mv |
https://purl.org/pe-repo/ocde/ford#3.02.21 |
| description |
Background: To assess the correlation of WHO histological classification and Masaoka-Koga staging system of thymic epithelial tumors (TETs) with prognosis. Methods: We retrospectively analyzed 83 patients with TETs in the Instituto Nacional de Enfermedades Neoplasicas between 1996 to 2018. We analyzed the clinical stages, histological types and treatment modalities and attempted to determine the impact on overall survival. The data was retrieved from clinical files and reviewed by a pathologist who reclassificated according to the 2004 WHO classification system. The staging was performed with the Masaoka-Koga staging system. Survival curves were constructed with Kaplan-Meir method. Results: There was a total of 83 patients with a median age of 55 years old included in the study. The histological type corresponded to thymoma (T) in 63.8% (n = 53) and to thymic carcinoma (TC) in 36.1%. T were type A, AB, B1, B2 and B3 in 14.4%, 18%, 12%, 3.6%, 7.4% of cases, respectively. The proportion of advanced disease (Masaoka stage III-IV) was high (65%). With a median follow-up of 88.4 months, median overall survival (OS) was 81.6 months for T and 12.3 months for TC (P = 0.01). Univariate analysis showed that sex, histological type, clinical stage and surgery (P = 0.01) were significant independent prognostic factors. On multivariate analysis, histology type and Masaoka-Koga staging had an effect on survival. Conclusions: The results indicates a clear association between the WHO histological classification and Masaoka-Koga staging system with survival. We found a higher proportion of TETs with advanced disease at diagnosis. Further research are required and collaboration is important to foster knowledge focused on classification and treatment. |
| publishDate |
2021 |
| dc.date.accessioned.none.fl_str_mv |
2024-06-13T15:50:48Z |
| dc.date.available.none.fl_str_mv |
2024-06-13T15:50:48Z |
| dc.date.issued.fl_str_mv |
2021 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
https: //doi.org/10.1111/1759-7714.13760 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.14703/102 |
| dc.identifier.journal.none.fl_str_mv |
Thorac Cancer |
| url |
https: //doi.org/10.1111/1759-7714.13760 https://hdl.handle.net/20.500.14703/102 |
| identifier_str_mv |
Thorac Cancer |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
International Association for the Study of Lung Cancer |
| dc.publisher.country.none.fl_str_mv |
US |
| publisher.none.fl_str_mv |
International Association for the Study of Lung Cancer |
| dc.source.none.fl_str_mv |
reponame:INEN-Institucional instname:Instituto Nacional de Enfermedades Neoplásicas instacron:INEN |
| instname_str |
Instituto Nacional de Enfermedades Neoplásicas |
| instacron_str |
INEN |
| institution |
INEN |
| reponame_str |
INEN-Institucional |
| collection |
INEN-Institucional |
| bitstream.url.fl_str_mv |
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/e13a67f0-b5c0-4c85-b3b3-a61085d76772/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/cb661171-7f18-4d2b-aa2c-aeb764e6fdd7/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/74f0fcaa-d942-476e-9633-f3ceb095bfe9/download |
| bitstream.checksum.fl_str_mv |
cfce7875a2f3128e1f599e2c9b37e1a0 45029c6da8048d7f4c68d3a9fb9586db caddb68e3efa8a9f06440735f26465f9 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio del Instituto Nacional de Enfermedades Neoplásicas |
| repository.mail.fl_str_mv |
repositorio@inen.sld.pe |
| _version_ |
1868438562113847296 |
| score |
12.821158 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).